|
Fibrinolysis
Citations 71-80 of 146 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis
- Albert Schömig, Gjin Ndrepepa, Julinda Mehilli, Markus Schwaiger, Helmut Schühlen, Stephan Nekolla, Jürgen Pache, Stefan Martinoff, Hildegard Bollwein, and Adnan Kastrati
Circulation 2003;108:1084-1088; published online before print as doi:10.1161/01.CIR.0000086346.32856.9C
[Abstract]
[Full text]
- Articles
Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction. The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial
- Kenneth W. Mahaffey, Christopher B. Granger, Jose C. Nicolau, Witold Ruzyllo, W. Douglas Weaver, Pierre Theroux, Judith S. Hochman, Thomas G. Filloon, Christopher F. Mojcik, Thomas G. Todaro, Paul W. Armstrong for the COMPLY Investigators
Circulation published August 18, 2003, doi:10.1161/01.CIR.0000087404.53661.F8
[Abstract]
- Articles
Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis
- Albert Schömig, Gjin Ndrepepa, Julinda Mehilli, Markus Schwaiger, Helmut Schühlen, Stephan Nekolla, Jürgen Pache, Stefan Martinoff, Hildegard Bollwein, and Adnan Kastrati
Circulation published August 18, 2003, doi:10.1161/01.CIR.0000086346.32856.9C
[Abstract]
- Editorials
Plasminogen Activator Inhibitor-1 and the Calculus of Mortality After Myocardial Infarction
- Douglas E. Vaughan
Circulation 2003;108:376-377, doi:10.1161/01.CIR.0000082929.85234.E7
[Full text]
- Clinical Investigations and Reports
Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease
- Sonia S. Anand, Qilong Yi, Hertzel Gerstein, Eva Lonn, Ruby Jacobs, Vlad Vuksan, Koon Teo, Bonnie Davis, Patty Montague, and Salim Yusuf
Circulation 2003;108:420-425; published online before print as doi:10.1161/01.CIR.0000080884.27358.49
[Abstract]
[Full text]
- Clinical Investigations and Reports
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction
- L. Wallentin, P. Goldstein, P.W. Armstrong, C.B. Granger, A.A.J. Adgey, H.R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Mäkijärvi, F. Verheugt, and F. Van de Werf
Circulation 2003;108:135-142; published online before print as doi:10.1161/01.CIR.0000081659.72985.A8
[Abstract]
[Full text]
- Articles
Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease
- Sonia S. Anand, Qilong Yi, Hertzel Gerstein, Eva Lonn, Ruby Jacobs, Vlad Vuksan, Koon Teo, Bonnie Davis, Patty Montague, Salim Yusuf for the Study of Health Assessment and Risk in Ethnic groups (SHARE) and Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP) Investigators
Circulation published July 14, 2003, doi:10.1161/01.CIR.0000080884.27358.49
[Abstract]
- Clinical Investigations and Reports
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction
- L. Wallentin, P. Goldstein, P. W. Armstrong, C. B. Granger, A. A.J. Adgey, H. R. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Mäkijärvi, F. Verheugt, and F. Van de Werf
Circulation published July 7, 2003, doi:10.1161/01.CIR.0000081659.72985.A8
[Abstract]
[Full text]
- Mini-Review: Expert Opinions
Fibrinolysis for Acute Myocardial Infarction: The Future Is Here and Now
- Paul W. Armstrong, Désiré Collen, and Elliott Antman
Circulation 2003;107:2533-2537, doi:10.1161/01.CIR.0000072930.64775.DC
[Full text]
- Mini-Review: Expert Opinions
Fibrinolytic Therapy: Is It A Treatment of the Past?
- Cindy L. Grines, Patrick Serruys, and William W. O’Neill
Circulation 2003;107:2538-2542, doi:10.1161/01.CIR.0000075292.29458.BB
[Full text]
|
|
